Prosthesis for inguinal hernia repair

Information

  • Patent Grant
  • 10675137
  • Patent Number
    10,675,137
  • Date Filed
    Friday, April 27, 2018
    6 years ago
  • Date Issued
    Tuesday, June 9, 2020
    4 years ago
Abstract
The present invention relates to a prosthesis for repairing a inguinal hernia defect. The prosthesis includes a piece of biocompatible material having a preformed three-dimensional shape including: a first portion forming a partial spherical cap surface, shaped and dimensioned so as to substantially conform to the shape of the anterior abdominal wall; a second portion extending from an inferior edge of the first portion and forming a wavy-shaped wall, shaped and dimensioned so as to substantially conform to the shape of the psoas muscle; and a third portion forming an arched part extending longitudinally in the inferior direction from a medial inferior corner of the first portion, the arched part extending radially substantially in the front direction, the third portion being intended to face the medial inferior area of the inguinal anatomy.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims benefit of and priority to European Patent Application Serial No. 17305489.1 filed May 2, 2017, the disclosure of the above-identified application is hereby incorporated by reference in its entirety.


BACKGROUND

The present invention relates to a preformed three-dimensional prosthesis to be used for repair of inguinal hernias.


SUMMARY

In this application, the “medial” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the median plane of the body when the prosthesis is implanted in the body. The “lateral” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the outwards lateral plane of the body when the prosthesis is implanted in the body. Likewise, in this application, the “medial direction” is to be understood as meaning the direction towards said median plane and the “lateral direction” is opposite the “medial direction”, the medial and lateral directions being aligned on the same axis, the medial-lateral axis. In this application, the “superior” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located substantially in the direction of the head of the body when the prosthesis is implanted in the body. The “inferior” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the feet of the body when the prosthesis is implanted in the body. Likewise, in this application, the “superior direction” is to be understood as meaning the direction towards said head and the “inferior direction” is opposite the “superior direction”, the superior and inferior directions being aligned on the same axis, the superior-inferior axis. In this application, the “front” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located substantially in the direction of the front of the body when the prosthesis is implanted in the body. The “rear” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the back of the body when the prosthesis is implanted in the body. Likewise, in this application, the “front direction” is to be understood as meaning the direction towards said front and the “rear direction” is opposite the “front direction”, the front and rear directions being aligned on the same axis, the front-rear axis.


The abdominal wall in humans is composed of fat and muscles interconnected by fascias. It sometimes happens that a break in continuity occurs in the fascias, allowing part of the peritoneum to slip through and form a sac, or a hernia, containing either fat or part of the intestines. Hernias or incisional hernias (a hernia occurring through a parietal surgical scar) show themselves in the form of a bulge at the surface of the skin and are classed, for example, as umbilical or inguinal hernias, depending on where they are located.


Wall reinforcement prostheses, for example for the abdominal wall, are widely used in surgery. These prostheses are intended to treat hernias by temporarily or permanently filling a tissue defect. These prostheses are generally made from a biocompatible prosthetic textile and can have a number of shapes, for example rectangular, circular or oval, depending on the anatomical structure to which they are to adapt. Some of these prostheses may show three-dimensional shapes.


Indeed, when an inguinal hernia is to be treated, it is of particular importance to take into account the anatomy of the inguinal region, in particular the presence of the iliac vessels. In addition, when the patient is a man, the spermatic cord needs to be taken into account while positioning the prosthesis. The various anatomical organs to be taken into account confer to the inguinal region to be treated a three-dimensional shape. In addition, the shape of the inguinal region being asymetric, the shape of a prosthesis intended to be used for treating an inguinal hernia will be dependent on the side (right or left) of the body that is to be treated. In this view, the shape of a prosthesis for treating an inguinal hernia may be defined in relation with the position of the prosthesis once implanted in the body of a patient. For example, in an implanted configuration, a three-dimensional prosthesis for treating an inguinal hernia may comprise a medial part, a lateral part, a superior part, an inferior part, a front part and a rear part as defined above.


With reference to FIG. 1, on which are indicated the medial-lateral axis A and the superior-inferior axis B, the anterior retro-parietal space of the inguinal region for the right hand side of a body is shown; in other words the inguinal region is shown from a view point located in the rear side of the body, for example from the interior of the abdominal cavity but with the peritoneum not shown on the Figure for sake of clarity, and looking towards the front side of the body, in other words in the direction of the abdominal skin of the body. On FIG. 1, one can see:

    • in direction of the front side of the body, the rectus abdominis muscles 116 and the transverse muscle 118 forming part of the anterior abdominal wall of the abdomen,
    • in the direction of the lateral side of the body, the psoas muscle 112, the iliac vessels 111, and the elements of the spermatic cord 120,
    • in the direction of the medial inferior side of the body, the upper part of the pubic bone 117.


On FIG. 1, are represented in dotted lines the three locations for potential hernias to occur in the inguinal region: the indirect inguinal hernia, shown as dotted line circle 122 on FIG. 1, occurs mainly in the lateral area of the inguinal region: it is a swelling of the groin caused when a portion of the peritoneum (not shown but located between the FIG. 1 and the person looking at FIG. 1), possibly containing abdominal viscera, passes through the orifice of the inguinal canal. It is necessary to push the peritoneum, and possibly the abdominal viscera, back in the direction of the abdominal cavity, and place a barrier, namely a prosthesis, between the peritoneum and the orifice of the inguinal canal. The direct hernia, shown as dotted line circle 119 on FIG. 1, occurs mainly in the medial area of the inguinal region. The femoral hernia, shown as dotted line circle 121 on FIG. 1, occurs mainly in the medial inferior area of the inguinal region.


It will be noted in FIG. 1 that the elements described above are not all in the same spatial plane, but instead are arranged in an oblique arrangement from a superior-lateral corner to an inferior-medial corner. In the case of an inguinal hernia, the prosthesis implanted after reduction of the hernia must ensure satisfactory covering of the hernia to be treated, either direct, indirect or femoral, by adapting to the contours of the region and by respecting the obliqueness of the inguinal region, if possible without leaving any empty spaces.


When operating by laparoscopy for repairing an inguinal hernia, two routes may be used for bringing the prosthesis to the implantation site, namely the inguinal region. For example, according to a first surgical method, namely the transabdominal preperitoneal route (TAPP), the prosthesis is first conveyed to the abdominal cavity via a trocar; the peritoneum is then open and the prosthesis is brought to the inguinal region through the incision performed through the peritoneum. The peritoneum is closed once the implantation is completed. According to a second surgical method, namely the totally extra-peritoneal route (TEP), the prosthesis is brought to the inguinal region through a trocar directly through the muscles of the abdominal wall, and the peritoneum is not open.


Because of the obliqueness of the inguinal region and the restricted deployment space, it can prove complicated to deploy the prosthesis and then orient it suitably with respect to the orifice of the inguinal canal or to the other organs to be protected, such as the illiac vessels or the spermatic cord.


The effectiveness of the prosthesis, hence the ability to minimize the risks of recurrence, depends to a large extent on how well the prosthesis is correctly spread out against the biological tissues of the inguinal region. In the present application, “biological tissues of the inguinal region” are understood as the biological tissues of the organs or elements of the inguinal region that are shown in FIG. 1 and that are intended to be protected from the peritoneum with a view to repairing the hernia, and in particular the anterior muscle wall, the upper part of the pubic bone, the iliac and spermatic vessels, and part of the psoas muscle.


Indeed, prostheses based on a textile are generally flexible. In order to introduce them into a trocar, they are often folded up or rolled to reduce their volume. They therefore tend to form creases when introduced at the implantation site. The spreading out of textile based prosthesis from the trocar is of key importance but can prove difficult.


Document U.S. Pat. No. 6,723,133 describes a preformed three-dimensional prosthesis for the repair of inguinal hernia intended to conform to the anatomical shape of the defective wall. The prosthesis described in this patent comprises a plurality of distinctly shaped portions joined to each other, all said shaped portions being configured with a substantially spherical shape.


As seen above, the anatomy of the inguinal region implies various organs such as muscles having various shapes, vessels, such as the illiac vessels, having various paths, and the pubic bone. In addition, the anatomy of the inguinal region may vary significantly from one human being to the other, in particular in its medial inferior area, in the surroundings of the upper part of the pubic bone. It has been observed that, with some preformed three-dimensional prostheses of the prior art, this medial inferior area of the inguinal region is not covered efficiently. In particular, depending on the true anatomy of the patient being treated, the surgeon may need to apply a certain tension on the prosthesis or shift the prosthesis at the moment of positioning the prosthesis, so that a part of the prosthesis be present in the medial inferior area of the inguinal region, namely in the surroundings of the pubic bone. Alternatively the surgeon may need to create folds in the prosthesis so as to conform it to the specific shape of the medial inferior area of the inguinal region he is confronted to in relation with the patient he is treating.


There is therefore still the need for a prosthesis for repair of inguinal hernias that is based on a preformed three-dimensional piece of biocompatible material intended to globally conform to the anatomical shape of the defective wall in the inguinal region, that is able to be spread out from the trocar and cover efficiently not only said defective wall but also the medial inferior area of the inguinal region, whatever the true anatomical shape of said medial inferior area in the patient to be treated, such that the surgeon does not have to apply specific tensions on the prosthesis or create folds when positioning the prosthesis with respect to the biological tissues.


The present invention aims to meet such a need.


A first aspect of the invention is an implantable prosthesis for repairing a hernia defect in an inguinal region of a human body delimited by the anterior abdominal wall, the psoas muscle and a medial inferior area of the inguinal anatomy, the prosthesis comprising:

    • a piece of biocompatible material having a preformed three-dimensional shape, the piece including:
    • a first portion, intended to face the anterior abdominal wall, said first portion forming a partial spherical cap surface shaped and dimensioned so as to substantially conform to the shape of the anterior abdominal wall,
    • a second portion, intended to face the psoas muscle, said second portion extending from an inferior edge of said first portion and forming a wavy-shaped wall, shaped and dimensioned so as to substantially conform to the shape of the psoas muscle, characterized in that said piece further comprises:
    • a third portion forming an arched part, said arched part extending longitudinally substantially in the inferior direction from a medial inferior corner of said first portion, said arched part extending radially substantially in the front direction, said third portion being intended to face the medial inferior area of the inguinal anatomy.


The prosthesis of the invention has a shape allowing it to conform ideally to the anatomy of the inguinal region to be reinforced. In particular, the shape and dimension of the first, second and third portions allow adapting the prostheses to different types of inguinal hernia, such as the direct inguinal hernia, the indirect inguinal hernia and the femoral inguinal hernia.


Moreover, the presence of the third portion of the prosthesis of the invention and the specific shape of this third portion allow covering the medial inferior area of the inguinal anatomy, in particular the region around the upper part of the pubic bone, without having to tear or stretch the other parts of the prosthesis or to create additional folds likely to undesirably interfere with the surrounding organs. Indeed, the presence of this third portion and its shape allow the surgeon to easily lay the entire prosthesis on each anatomical element to be protected without having to apply a particular compensating force on another part of the prosthesis or to shift the prosthesis. The prosthesis is perfectly spread out in the three dimensions of the inguinal region to be repaired, with no need to create folds in the prosthesis in order to conform it to the shape of the anatomy to be protected. There is no tension created in the prosthesis when it is positioned.


The prosthesis of the invention is intended to be used for repairing a hernia defect in the inguinal region of a human body. The prosthesis of the invention is particularly adapted for use in laparoscopic surgery, either via the transabdominal preperitoneal route (TAPP) or the totally extra-peritoneal route (TEP).


The inguinal region may be delimited by the anterior abdominal wall, the psoas muscle and a medial inferior area of the inguinal anatomy, in the surroundings of the pubic bone.


The prosthesis of the invention comprises a piece of biocompatible material having a preformed three-dimensional shape. The piece of biocompatible material comprises several portions, each having a determined shape, the assembly of these determined shapes forming the preformed three-dimensional shape. The piece of biocompatible material is preferably made as a unitary structure.


In the present application, “biocompatible” is understood as meaning that the materials having this property can be implanted in the human or animal body.


Biocompatible materials for forming hernia repair prosthesis are well known in the art. For example, the biocompatible material may comprise a bioresorbable, a non-bioresorbable material and mixtures thereof.


In the present application, “bioresorbable” or “biodegradable” is understood to mean that the materials having this property are absorbed and/or degraded by the tissues or washed from the implantation site and disappear in vivo after a certain time, which may vary, for example, from a few hours to a few years, depending on the chemical nature of the materials.


Examples of bioresorbable material suitable for the piece of the prosthesis of the invention can be chosen from among the following bioresorbable materials: polylactic acid (PLA), polycaprolactones (PCL), polydioxanones (PDO), trimethylene carbonates (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHA), oxidized cellulose, polyglycolic acid (PGA), polyethylene glycol (PE), copolymers of these materials, and mixtures thereof.


Examples of non-bioresorbable material suitable for the piece of the prosthesis of the invention can be chosen from among the following non-bioresorbable materials: polypropylenes, polyesters such as polyethylene terephthalates, polyamides, silicones, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK) and mixtures thereof.


The piece may be made from a preformed sheet of foam, preferably a porous material. Within the meaning of the present application, “porous material” is understood as a material having pores, voids or holes, that are open and are distributed uniformly or irregularly and promote cell colonization and tissue ingrowth. The pores can be present in all types of configurations, for example as spheres, channels, hexagonal forms.


In embodiments, the piece of biocompatible material comprises a textile, in particular a porous textile. In embodiments, the piece of biocompatible material consists in a textile, for example a porous textile.


According to the present invention, “textile” is understood as any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or non-woven. Biocompatible textiles, in particular porous textiles, suitable for the repair of a hernia defect are well known in the art.


The piece of biocompatible material of the prosthesis of the invention comprises a first portion forming a partial spherical cap surface. The partial spherical cap surface is intended to face the anterior abdominal wall. The partial spherical cap surface may extend in the front direction, namely towards the abdominal wall. The partial spherical cap surface is shaped and dimensioned so as to conform to the shape of the anterior abdominal wall. A spherical cap suitable for forming said first portion may derive from a sphere having a diameter ranging from about 200 mm to about 220 mm, preferably ranging from about 206 mm to about 215 mm, said spherical cap having a height ranging from about 15 mm to about 35 mm, preferably from about 20 mm to about 28 mm. The partial spherical cap suitable for obtaining the surface forming the first portion may result from the removal of an inferior part of the spherical cap along a wavy line forming an inferior edge of the first portion.


The piece of biocompatible material of the prosthesis of the invention comprises a second portion forming a wavy-shaped wall intended to face the psoas muscle. The wavy-shaped wall extends from the inferior edge of the first portion and is shaped and dimensioned so as to conform to the shape of the psoas muscle. In embodiments, the wavy-shaped wall extends substantially from a lateral side to a medial side of the piece of biocompatible material and it includes a surface generated by a generatrix, under the form of a straight line D, following a directrix, under the form of a directing curved line C. In embodiments, the directing curved line C includes at least a lateral curve extending substantially in the inferior direction and at least a central curve, offset in the medial direction with respect to said lateral curve, said central curve extending substantially in the superior direction. In embodiments, the directing curved line C further includes a medial curve extending substantially in the inferior direction. The presence or not of the medial curve may depend on the anatomy of the patient to be treated, in particular on the size of the hernia defect to be repaired.


For example, the radius of curvature of the lateral curve may range from about 50 mm to about 55 mm, and may preferably be about 53 mm, the radius of curvature of the central curve may range from about 20 mm to about 35 mm, and may preferably be from about 24 mm to about 31 mm, and the radius of curvature of the medial curve, when present, may range from about 70 mm to about 90 mm, and may preferably be about 80 mm.


The wavy-shaped wall is preferably inclined with respect to the direction of the height of the spherical cap of the first portion. In embodiments, the angle formed between the generatrix of the wavy-shaped wall and the direction of the height of the spherical cap of the first portion may range from about 35° to about 50°, preferably from about 40° to about 45°.


The piece of biocompatible material further comprises a third portion forming an arched part. The arched part extends longitudinally substantially in the inferior direction from a medial inferior corner of said first portion, said arched part extending radially substantially in the front direction, said third portion being intended to face the medial inferior area of the inguinal anatomy. By “arched part” is meant in the present application an angular section of a tube. The radius of the arched part according to the present application is the radius of the tube from which the arched part derives.


In embodiments, the arched part has a radius ranging from about 70 mm to about 110 mm, preferably from about 80 mm to about 100 mm. In embodiments, the arched part extends circumferentially along a portion of a circle forming an angle ranging from about 30° to about 45°, preferably ranging from 33° to 40°. The arched part may have a height ranging from about 20 mm to about 40 mm, preferably from about 21 mm to about 35 mm. The arched part may have a length ranging from about 40 mm to about 60 mm, preferably from about 45 mm to about 53 mm.


The arched part allows covering the various organs present in the medial inferior area of the inguinal region. In particular, the shape and dimension of the arched part allow spreading easily the prosthesis without having to tear it or to create specific folds in order to adapt to the unique anatomy of the patient to be treated.


In embodiments, the height of the arched part is greater or equal, preferably greater, than the height of the spherical cap of the first portion. The arched part is therefore allowed to cover the medial inferior area of the inguinal region while the spherical cap conforms to the shape of the anterior abdominal wall, without having to apply any specific tension on the prosthesis in the front or rear directions.


In embodiments, said preformed three-dimensional shape defining an edge of said piece, said edge extends in the three dimensions of the space. The edge of the piece of biocompatible material follows the anatomy of the region to be protected in an optimum way. In particular, thanks to the fact that the edge of the piece extends in the three dimensions of the space, there is no need for the surgeon to create additional folds of the prosthesis in order to conform it to the anatomic shape to be protected.


In embodiments, said preformed three-dimensional shape defining an edge of said piece, said edge is provided with a reinforcement member at least on a part of its perimeter. The reinforcement member may be made from any biocompatible material and may run continuously or discontinuously along the edge. The reinforcement member may be selected from a moulded material, a wire, a fused textile part and combinations thereof. The reinforcement member is usually provided with a rigidity superior to that of the piece of biocompatible material and may help the handling of the prosthesis during the surgical operation.


In embodiments, the reinforcement member shows no elasticity along the perimeter of the edge. In other words, if one holds the piece at two points of its edge located substantially on a linear section of said edge, and tries to draw away one point from the other, the reinforcement member will show no elongation between the two points. The reinforcement member may therefore constitute a sort of three-dimensional non-elastic belt maintaining the edge of the piece of biocompatible material, where such belt provides a pop-up effect at the time the prosthesis comes out of a trocar for example. The reinforcement member therefore contributes to a more efficient deployment of the prosthesis when it comes out of the trocar.


In embodiments, the piece of biocompatible material may show an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released. The surgeon may therefore be able to reduce the global volume of the prosthesis by applying an outer pressure on the prosthesis so as to fold it on itself at the time he introduces the prosthesis in the trocar. When the prosthesis is released from the trocar on the implantation site, namely in the inguinal region, the prosthesis comes naturally to its initial spread out three-dimensional shape.


A piece of biocompatible material showing such an elasticity may be made from a porous foam.


Alternatively, some textiles may form biocompatible material showing such an elasticity. A textile suitable for forming the piece of the prosthesis of the invention and showing an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released is described in U.S. Pat. No. 6,478,727. For example, such a textile may comprise a porous knit made of polypropylene monofilament yarn having a diameter ranging from about 0.12 mm to about 0.25 mm, preferably from about 0.15 mm to about and 0.20 mm, for example of about 0.18 mm, and threaded one full one empty in two guide bars according to the following knitting pattern according to ISO 11676 standard, publication 2014: Bar I: 3-2/2-1/0-1//, Bar II: 0-1/1-2/3-2//. For example, the number of stitches per centimeter for such a porous knit may vary from about 7 to 15, preferably from about 10 to 12.


In embodiments, the reinforcement member comprises a fused part of a contour of the textile forming the piece of biocompatible material. Alternatively, the reinforcement member may consist in a fused part of a contour of said textile. The fused part of the contour of a textile allows forming a reinforcement member having a smooth outer shape and free of any potential traumatic part. The fused part of the contour of a textile further allows forming a reinforcement member showing no elasticity along the perimeter of the edge. The fused part of the contour of the textile also allows avoiding the self-gripping of the textile.


The contour of the textile may be fused via thermal welding, such as thermal impulse sealing, ultrasonic welding, or induction welding. For example, when thermal impulse sealing is used, the contour of the textile is compressed between two jaws and heated to the melting point of the material forming the textile.


In embodiments, a medial inferior part of the edge is free of any reinforcement member. The absence of any reinforcement member at the medial inferior part of the edge of the piece of the prosthesis of the invention allows the surgeon to freely direct and position the medial inferior part of the prosthesis in function of the shape of the anatomical organs located in the area of the medial inferior area of the inguinal region. Indeed, it is known that the anatomy of the medial inferior area of the inguinal region varies significantly from one human being to the other. Leaving the medial inferior part of the prosthesis free of any reinforced edge enables the surgeon to adapt the positioning and to customize the fixation of the prosthesis in this area to the true shape of the anatomy encountered for a specific patient. The medial inferior part of the prosthesis is therefore more conformable to the anatomical relief encountered in the treated patient.


In embodiments, the piece of biocompatible material is a textile showing an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released, having a reinforcement member which is a fused part of said textile, where the medial inferior part of the edge is free of any reinforcement member. Such embodiments allow having a non-elastic belt, formed by the reinforcement member, maintaining the prosthesis on the main part of its edge, while leaving the medial inferior part of the edge preserve its elasticity, coming from the elasticity of the textile it is made of. Such embodiments allow the surgeons to benefit from the elasticity of the medial inferior part of the edge of the textile in order to easily move the prosthesis in the medial inferior area of the inguinal region and to more freely adapt the position of the prosthesis to this specific part of the anatomy, while at the same time having a prosthesis that has enough global rigidity to be manipulated efficiently and to be spread out easily from the trocar.


In embodiments, the piece further includes a fourth portion extending from the superior-medial part of the first portion, said fourth portion forming a triangular part defining a superior-medial corner of the prosthesis, said corner forming an angle ranging from about 100° to about 120°, preferably from about 105° to about 115°, for example of about 110°. Such a fourth portion allows providing an indication to the surgeon for better positioning the prosthesis. In particular, such a fourth portion helps the surgeon to orientate the prosthesis with regards to the Linea Alba. In addition, the presence of the triangular part forming the fourth portion of the prosthesis allows increasing the surface of the prosthesis in the medial superior area of the inguinal region. Such embodiments are particularly preferred for direct inguinal hernia as they consequently provide additional reinforcement in said medial superior area.


The preformed three-dimensional shape of the prosthesis of the invention may be obtained using any preforming process known in the art, such as a compressive thermoforming process using a traditional two-parts mold. For example, a first part of the mold exhibits an outer surface having the desired shape for the piece of the prosthesis to be obtained and a second part of the mold has a shape similar to that of the first part but recessed into its inner surface. The sheet of biocompatible material, for example a textile, is then secured between the first and the second parts of the mold, the whole being heated at a temperature ranging from about 140° C. to about 150° C. and further cooled down. The preformed three-dimensional shaped piece thus obtained is removed from the mold.





BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will become clearer from the following description and from the attached drawings, in which:



FIG. 1 is a schematic view of the inguinal region,



FIG. 2A is a top view of a first embodiment of a prosthesis of the invention,



FIG. 2B is a top view of a second embodiment of the prosthesis of the invention,



FIG. 3A is a side perspective view of the prosthesis of FIG. 2A,



FIG. 3B is a cross section view of the prosthesis of FIG. 3A taken along line I-I, showing the angle between the direction of the height of the spherical cap and the generatrix of the wavy-shaped wall,



FIG. 4 is a side view of the prosthesis of FIG. 2A showing the radius of the arched part, the angle of the portion of a circle on which extends the arched part, and the height of the arched part,



FIG. 5 is a schematic top view of the first portion of the prosthesis of FIG. 2A showing the radius of curvature of the curves of the wavy-shaped wall.





DETAILED DESCRIPTION OF EMBODIMENTS

With reference to FIG. 2A, is shown a prosthesis 1 of the invention for repairing a hernia defect in an inguinal region of the human body. The prosthesis 1 shown on FIG. 1 is intended to be implanted in the left hand side of a patient body. The prosthesis 1 comprises a piece 2 of biocompatible material having a preformed three-dimensional shape. On FIG. 2A are indicated the medial-lateral axis A and the superior-inferior axis B. The preformed piece 2 of FIG. 2A has a lateral side 2a, a medial side 2b, a superior side 2c and an inferior side 2d. On FIG. 2A is shown the front side of the prosthesis 1.


The piece 2 comprises a first portion 3, which is intended to face the anterior abdominal wall, a second portion 4, which is intended to face the psoas muscle and a third portion 5, which is intended to face the medial inferior area of the inguinal region. In the example shown the piece 2 further comprises a fourth portion 6, intended to ease the alignment of the prosthesis 1 on the Linea Alba. In embodiments not shown, the piece 2 does not comprise such fourth portion. The first portion 3, second portion 4, third portion 5 and fourth portion 6 are all united to form the preformed three-dimensional shaped piece 2 as a unitary structure. The piece 2 has an edge 7 defined by the contour of its preformed three-dimensional shape.


Each portion (3, 4, 5, 6) of the piece 2 of biocompatible material will now be described in detail.


The first portion 3 forms a partial spherical cap surface 8. The partial spherical cap surface 8 is intended to face the anterior abdominal wall once the prosthesis 1 is implanted in the body of a patient. The partial spherical cap surface 8 therefore extends in the front direction, namely towards the abdominal wall. The partial spherical cap surface 8 is shaped and dimensioned so as to conform to the curved shape of the anterior abdominal wall. The partial spherical cap surface 8 is further intended to be positioned adjacent the psoas muscle in an implanted configuration. In this view, the partial spherical cap surface 8 is derived from a spherical cap from which an inferior part has been removed, the inferior part removed corresponding to the presence of the psoas muscle. The partial spherical cap surface 8 may therefore be a spherical cap surface that has been cut in its inferior part along a line delimited by the shape of the psoas muscle. Such a line forms an inferior edge 8a of the partial spherical cap surface 8.


The spherical cap from which the first portion 3 is formed may be obtained from the cutting of a cap from a sphere having a diameter ranging from about 200 mm to about 220 mm, preferably ranging from about 206 mm to about 215 mm, where the cut cap has a height H, as shown on FIG. 4, ranging from about 15 mm to about 35 mm, preferably from about 20 mm to about 28 mm. The partial spherical cap surface 8 forming the first portion 3 may result from the removal of an inferior part of such a spherical cap along a wavy line forming the inferior edge 8a of the partial spherical cap 8 and of the first portion 3.


The second portion 4 forms a wavy-shaped wall 9 intended to face the psoas muscle once the prosthesis 1 is implanted in the body of a patient. The wavy-shaped wall 9 extends from the inferior edge 8a of the first portion 3 and is shaped and dimensioned so as to conform to the shape of the psoas muscle.


With reference to FIG. 2A, the wavy-shaped wall 9 extends from a lateral side 2a to substantially a medial side 2b of the piece 2. The wavy-shaped wall 9 includes a surface generated by a generatrix, under the form of a straight line D shown for example on FIGS. 3A and 3B, following a directrix, under the form of a directing curved line C shown for example on FIG. 5. The wavy-shaped wall 9 may comprise a succession of several curves, for example two or three curves, forming a wave. In the example shown in FIG. 2A, the wavy-shaped wall 9 comprises three curves, namely a lateral curve 9a extending substantially in the inferior direction, a central curve 9b extending substantially in the superior direction and a medial curve 9c extending in the inferior direction.


With reference to FIG. 5, is shown a schematic top view of the first portion 3 of FIG. 2A showing the directing curved line C including the lateral curve 9a, the central curve 9b and the medial curve 9c and their corresponding radius of curvatures (R1, R2, R3).


For example, the radius of curvature of the lateral curve 9a, shown as R1 on FIG. 5, may range from about 50 mm to about 55 mm, and may preferably be about 53 mm, the radius of curvature of the central curve 9b, shown as R2 on FIG. 5, may range from about 20 mm to about 35 mm, and may preferably be from about 24 mm to about 31 mm, and the radius of curvature of the medial curve 9c, shown as R3 on FIG. 5, may range from about 70 mm to about 90 mm, and may preferably be about 80 mm.


The wavy-shaped wall 9 is inclined with respect to the direction of the height “h” of the spherical cap 8 of the first portion 3. With reference to FIGS. 3A and 3B, the angle α formed between the generatrix D of the wavy-shaped wall and the direction “h” of the height of the spherical cap surface 8 of the first portion 3 may range from about 35° to about 50°, preferably from about 40° to about 45°.


With reference to FIG. 2B, is shown a second embodiment of the prosthesis 1 of FIG. 1, in which the wavy-shaped wall 9 does not comprise any medial curve. As will appear from the description below, the prosthesis of FIG. 2B may be designed for cases where the size of the hernia defect in the medial inferior area of the inguinal region requires high coverage from the prosthesis 1. The third portion 5 is made larger and replaces the medial curve of the wavy-shaped wall 9.


With reference to FIG. 2A, the third portion 5 forms an arched part 10. The arched part 10 extends longitudinally substantially in the inferior direction from a medial inferior corner 3a of the first portion 3. As better seen on FIG. 4, the arched part 10 extends radially substantially in the front direction.


The arched part 10 forming the third portion 5 is intended to face the medial inferior area of the inguinal anatomy. The radius R4 of the arched part 10 is the radius of the tube from which the arched part derives and is shown in FIG. 4.


The arched part 10 may have a radius R4 ranging from about 70 mm to about 110 mm, preferably from about 80 mm to about 100 mm.


With reference to FIG. 4, the arched part 10 extends circumferentially along a portion of a circle forming an angle β ranging from about 30° to about 45°, preferably ranging from 33° to 40°.


Still with reference to FIG. 4, the arched part 10 may have a height J ranging from about 20 mm to about 40 mm, preferably from about 21 mm to about 35 mm. With reference to FIGS. 2A and 2B, the arched part 10 may have a length L ranging from about 40 mm to about 60 mm, preferably from about 45 mm to about 53 mm.


The arched part 10 allows covering the various organs present in the medial inferior area of the inguinal region. In particular, the shape and dimension of the arched part 10 allow spreading easily the prosthesis 1 without having to tear it or to create specific folds in order to adapt to the unique anatomy of the patient to be treated.


Still with reference to FIG. 4, the height J of the arched part 10 is greater than the height H of the spherical cap of the first portion 3. Once the prosthesis 1 is implanted, the arched part 10 is thus allowed to cover the medial inferior area of the inguinal region while the spherical cap surface 8 conforms to the shape of the anterior abdominal wall, without having to apply any specific tension on the prosthesis in the front or rear directions.


With reference to FIG. 2A, the fourth portion 6 extends from the superior-medial part of the first portion 3. The fourth portion 3 forms a triangular part 12 defining a superior-medial corner of the prosthesis 1. For example, this corner may form an angle γ, as shown on FIG. 2A, ranging from about 100° to about 120°, preferably from about 105° to about 115°, for example of about 110°. The triangular part 12 allows the prosthesis 1 to provide an additional reinforcement in the medial superior area of the inguinal region. Such embodiments are particularly suitable when the hernia to be repaired is a direct inguinal hernia. The presence of the fourth portion 6 may also help the surgeon positioning optimally the prosthesis 1 by making the medial edge of the prosthesis 1 more visible to the surgeon. The surgeon may then more easily align the medial edge of the prosthesis 1 with the Linea Alba.


With reference to FIG. 4, one can see that the edge 7 extends in the three dimensions of the space. This allows the piece 2 to follow the anatomy of the region to be protected in an optimum way.


With reference to FIG. 2A, the edge 7 is provided with a reinforcement member 11.


The reinforcement member 11 forms a non-elastic belt maintaining the prosthesis 1 and helps the handling of the prosthesis 1 while providing a pop-up effect when the prosthesis 1 has been folded on itself, like in a trocar for example.


On FIG. 2A, the reinforcement member 11 runs along a part of the edge 7 while leaving free the medial inferior part of said edge 7. In particular, the reinforcement member 11 runs from a first end 11a, approximately located at the level of the central curve 9b, to a second end 11b, approximately located at the medial-inferior corner of the arched part 5, leaving free the medial inferior part of the edge 7. Such an embodiment, where the edge 7 is reinforced except in its medial inferior part, allows obtaining both the required pop-up effect for the deployment of the prosthesis 1 out of a trocar and the possibility to adapt and conform the third portion 5, namely the arched part 10, to the true anatomy of the medial inferior area of the inguinal region of the patient treated.


The four portions (3, 4, 5, 6) of the prosthesis 1 of FIG. 2A are made from a biocompatible material. The biocompatible material may comprise a bioresorbable, a non-bioresorbable material and mixtures thereof.


The four portions (3, 4, 5, 6) of the prosthesis 1 of FIG. 2A are preferably made from a porous textile, in particular a textile showing an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released. Such a textile may for example be a porous knit made of polypropylene monofilament yarn having a diameter ranging from about 0.12 mm to about 0.25 mm, preferably from about 0.15 mm to about and 0.20 mm, for example of about 0.18 mm, and threaded one full one empty in two guide bars according to the following knitting pattern according to ISO 11676 standard, publication 2014: Bar I: 3-2/2-0/0-1//, Bar II: 0-1/1-2/3-2//. For example, the number of stitches per centimeter for such a porous knit may vary from about 7 to 15, preferably from about 10 to 12.


The reinforcement member 11 may be a fused part of the contour of the textile forming the piece 2, for example obtained by thermal welding. Such a fused part shows a smooth outer shape and is free of any traumatic element. Such a fused part also allows avoiding self-gripping of the textile when the prosthesis is folded on itself during its introduction to the implantation site via a trocar.


When the textile is a porous knit obtained from polypropylene monofilament as described above, the reinforcement member may be obtained by fusing the contour of the textile as follows: the contour of the textile is compressed between two jaws and heated to about 240° C. which is the melting point of polypropylene.


The piece 2 of the prosthesis 1 may be obtained using a compressive thermoforming process: for example, a flat textile such as the textile described above is secured between the two parts of a mold having the desired shape for the piece of the prosthesis to be obtained. The whole is heated at temperature of about 140° C. and then cooled down in order to obtain the preformed three-dimensional shaped piece 2. The preformed three-dimensional shaped piece thus obtained from said textile shows an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released. Fusing the edge of the piece except for the medial inferior part of the edge allows forming a prosthesis capable of spreading out automatically from a trocar and having a good handleability, while showing in its medial inferior part an elasticity enabling the surgeon to conform the prosthesis to the medial inferior area of the inguinal region of the patient being treated.


The prosthesis of the invention is adapted to be used in the repair of inguinal hernia, such as the direct inguinal hernia, the indirect inguinal hernia and/or the femoral inguinal hernia. In particular, the prosthesis of the invention allows covering the medial inferior area of the inguinal anatomy, in particular the region around the upper part of the pubic bone, without having to tear or stretch the other parts of the prosthesis or to create additional folds likely to undesirably interfere with the surrounding organs.

Claims
  • 1. An implantable prosthesis for repairing a hernia defect in an inguinal region of a human body delimited by the anterior abdominal wall, the psoas muscle and a medial inferior area of the inguinal anatomy, the prosthesis comprising: a piece of biocompatible material having a preformed three-dimensional shape including a lateral side and a medial side extending along a medial-lateral axis and a superior side and inferior side extending along a superior-inferior axis, the piece including:a first portion, configured to face the anterior abdominal wall, said first portion forming a partial spherical cap surface shaped and dimensioned so as to substantially conform to the anterior abdominal wall and including an inferior edge extending between the lateral and medial sides,a second portion, configured to face the psoas muscle, said second portion extending in an inferior direction from at least a lateral portion of the inferior edge of said first portion and forming a wavy-shaped wall, shaped and dimensioned so as to substantially conform to the psoas muscle, anda third portion forming an arched part, said arched part extending longitudinally substantially in the inferior direction from at least a medial portion of the inferior edge of said first portion, said arched part extending radially substantially in a front direction, said third portion being configured to face the medial inferior area of the inguinal anatomy.
  • 2. The prosthesis of claim 1, wherein said preformed three-dimensional shape defines an edge of said piece, said edge extending in three dimensions.
  • 3. The prosthesis of claim 2, wherein said edge is provided with a reinforcement member at least on a part of a perimeter of said edge.
  • 4. The prosthesis of claim 3, wherein a medial inferior part of the edge is free of any reinforcement member.
  • 5. The prosthesis of claim 3, wherein the piece of biocompatible material comprises a textile.
  • 6. The prosthesis of claim 5, wherein the reinforcement member comprises a fused part of a contour of said textile.
  • 7. The prosthesis of claim 3, wherein said reinforcement member shows no elasticity along the perimeter of the edge.
  • 8. The prosthesis of claim 1, wherein the piece of biocompatible material shows an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released.
  • 9. The prosthesis of claim 1, wherein the spherical cap of said first portion derives from a sphere having a diameter ranging from about 200 mm to about 220 mm, and said spherical cap has a height ranging from about 15 mm to about 35 mm.
  • 10. The prosthesis of claim 1, wherein the spherical cap of said first portion derives from a sphere having a diameter ranging from about 206 mm to about 215 mm, and said spherical cap has a height ranging from about 20 mm to about 28 mm.
  • 11. The prosthesis of claim 1, said wavy-shaped wall includes a surface generated by a generatrix, under a form of a straight line, following a directrix, under a form of a directing curved line.
  • 12. The prosthesis of claim 11, wherein said directing curved line includes at least a lateral curve extending substantially in the inferior direction and at least a central curve, offset in a medial direction with respect to said lateral curve, said central curve extending substantially in a superior direction.
  • 13. The prosthesis of claim 12, wherein a radius of curvature of the lateral curve ranges from about 50 mm to about 55 mm, and a radius of curvature of the central curve ranges from about 20 mm to about 35 mm.
  • 14. The prosthesis of claim 12, wherein a radius of curvature of the lateral curve ranges is about 53 mm, and a radius of curvature of the central curve ranges from about 24 mm to about 31 mm.
  • 15. The prosthesis of claim 13, wherein the directing curved line further includes a medial curve extending in the inferior direction.
  • 16. The prosthesis of claim 15, wherein a radius of curvature of the medial curve ranges from about 70 mm to about 90 mm.
  • 17. The prosthesis of claim 15, wherein a radius of curvature of the medial curve is about 80 mm.
  • 18. The prosthesis of claim 11, wherein an angle formed between the generatrix of the wavy-shaped wall and a direction of a height of the spherical cap of the first portion ranges from about 35° to about 50°.
  • 19. The prosthesis of claim 11, wherein an angle formed between the generatrix of the wavy-shaped wall and a direction of a height of the spherical cap of the first portion ranges from about 40° to about 45°.
  • 20. The prosthesis of claim 1, wherein the arched part has a radius ranging from about 70 mm to about 110 mm.
  • 21. The prosthesis of claim 1, wherein the arched part has a radius ranging from about 80 mm to about 100 mm.
  • 22. The prosthesis of claim 1, wherein the arched part extends circumferentially along a portion of a circle forming an angle ranging from about 30° to about 45°.
  • 23. The prosthesis of claim 1, wherein the arched part extends circumferentially along a portion of a circle forming an angle ranging from 33° to 40°.
  • 24. The prosthesis of claim 1, wherein the arched part has a height ranging from about 20 mm to about 40 mm.
  • 25. The prosthesis of claim 1, wherein the arched part has a height ranging from about 21 mm to about 35 mm.
  • 26. The prosthesis of claim 1, wherein the arched part has a length ranging from about 40 mm to about 60 mm.
  • 27. The prosthesis of claim 1, wherein the arched part has a length ranging from about 45 mm to about 53 mm.
  • 28. The prosthesis of claim 1, wherein the piece further includes a fourth portion extending from a superior-medial part of the first portion, said fourth portion forming a triangular part defining a superior-medial corner of the prosthesis, said corner forming an angle ranging from about 100° to about 120°.
  • 29. The prosthesis of claim 28, wherein said corner forms an angle ranging from about 105° to about 115°.
  • 30. The prosthesis of claim 1, wherein a height of the arched part is greater or equal than a height of the spherical cap of the first portion.
  • 31. The prosthesis of claim 1, wherein a height of the arched part is greater than a height of the spherical cap of the first portion.
Priority Claims (1)
Number Date Country Kind
17305489 May 2017 EP regional
US Referenced Citations (490)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
3054406 Usher Sep 1962 A
3118294 Van Laethem Jan 1964 A
3124136 Usher Mar 1964 A
3272204 Charles et al. Sep 1966 A
3276448 Usher Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Emoto et al. Mar 1971 A
3718725 Hamano Feb 1973 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Pendergrass et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Schafer et al. Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Huc et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4840629 Bustos Jun 1989 A
4841962 Berg et al. Jun 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
4976737 Leake Dec 1990 A
5002551 Linsky et al. Mar 1991 A
5015584 Brysk May 1991 A
5071433 Naestoft et al. Dec 1991 A
5116357 Eberbach May 1992 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5195542 Gazielly et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5258000 Gianturco Nov 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 McMurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 McVicker Nov 1994 A
5368602 de la Torre Nov 1994 A
5370650 Tovey et al. Dec 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5584884 Pignataro Dec 1996 A
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5676967 Williams et al. Oct 1997 A
5681568 Goldin et al. Oct 1997 A
5686090 Schilder et al. Nov 1997 A
5686115 Voumakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5702416 Kieturakis et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5711960 Shikinami Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5743917 Saxon Apr 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 McGregor et al. Feb 1999 A
5871767 Dionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5954767 Pajotin et al. Sep 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6090116 D'Aversa et al. Jul 2000 A
6113623 Sgro Sep 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 DiCosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6162962 Hinsch et al. Dec 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6180848 Flament et al. Jan 2001 B1
6197325 MacPhee et al. Mar 2001 B1
6197934 DeVore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306079 Trabucco Oct 2001 B1
6306424 Vyakamam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6319264 Tormala et al. Nov 2001 B1
6328686 Kovac Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6368541 Pajotin et al. Apr 2002 B1
6383201 Dong May 2002 B1
6391060 Ory et al. May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6425924 Rousseau Jul 2002 B1
6428978 Dlsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 DeVore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6485503 Jacobs et al. Nov 2002 B2
6500464 Ceres et al. Dec 2002 B2
6500777 Wiseman et al. Dec 2002 B1
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6610006 Amid et al. Aug 2003 B1
6613348 Jain Sep 2003 B1
6616685 Rousseau Sep 2003 B2
6623963 Muller et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6637437 Hungerford et al. Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6645226 Jacobs et al. Nov 2003 B1
6652594 Francis et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6670018 Fujita et al. Dec 2003 B2
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6712859 Rousseau et al. Mar 2004 B2
6719795 Cornwall et al. Apr 2004 B1
6723133 Pajotin Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6726660 Hessel et al. Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6737371 Planck et al. May 2004 B1
6740122 Pajotin May 2004 B1
6743435 DeVore et al. Jun 2004 B2
6746458 Cloud Jun 2004 B1
6752834 Geistlich et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul Malak et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6872227 Sump et al. Mar 2005 B2
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6984392 Bechert et al. Jan 2006 B2
6988386 Okawa et al. Jan 2006 B1
7011688 Gryska et al. Mar 2006 B2
7021086 Ory et al. Apr 2006 B2
7022358 Eckmayer et al. Apr 2006 B2
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
7060103 Carr, Jr. et al. Jun 2006 B2
RE39172 Bayon et al. Jul 2006 E
7070558 Gellman et al. Jul 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7094261 Zotti et al. Aug 2006 B2
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156804 Nicolo Jan 2007 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7252837 Guo et al. Aug 2007 B2
7279177 Looney et al. Oct 2007 B2
7331199 Ory et al. Feb 2008 B2
7393319 Merade et al. Jul 2008 B2
7476249 Frank Jan 2009 B2
7556598 Rao Jul 2009 B2
7594921 Browning Sep 2009 B2
7614258 Cherok et al. Nov 2009 B2
7615065 Priewe et al. Nov 2009 B2
7662169 Wittmann Feb 2010 B2
7670372 Shfaram et al. Mar 2010 B2
7670380 Cauthen, III Mar 2010 B2
7682381 Rakos et al. Mar 2010 B2
7709017 Tayot May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7789888 Bartee et al. Sep 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7828854 Rousseau et al. Nov 2010 B2
7900484 Cherok et al. Mar 2011 B2
7931695 Ringeisen Apr 2011 B2
7998152 Frank Aug 2011 B2
8007531 Frank Aug 2011 B2
8052759 Dupic et al. Nov 2011 B2
8079023 Chen Dec 2011 B2
8100924 Browning Jan 2012 B2
8123817 Intoccia et al. Feb 2012 B2
8142515 Therin et al. Mar 2012 B2
8157821 Browning Apr 2012 B2
8157822 Browning Apr 2012 B2
8182545 Cherok et al. May 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8206632 Rousseau et al. Jun 2012 B2
8215310 Browning Jul 2012 B2
8317872 Adams Nov 2012 B2
8323675 Greenawalt Dec 2012 B2
8343232 Adzich et al. Jan 2013 B2
8366787 Brown et al. Feb 2013 B2
8435307 Paul May 2013 B2
8470355 Skalla et al. Jun 2013 B2
8506627 Van Epps et al. Aug 2013 B2
8562633 Cully et al. Oct 2013 B2
8574627 Martakos et al. Nov 2013 B2
8709094 Stad et al. Apr 2014 B2
8728159 Kim May 2014 B2
8734471 Deitch May 2014 B2
8746014 Mortarino Jun 2014 B2
8753360 Gleiman et al. Jun 2014 B2
8758800 Stopek et al. Jun 2014 B2
8784294 Goddard Jul 2014 B2
8814887 Walther et al. Aug 2014 B2
8828092 Toso et al. Sep 2014 B2
8834864 Odar et al. Sep 2014 B2
8846060 Archibald et al. Sep 2014 B2
8865215 Ladet et al. Oct 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8911504 Mathisen et al. Dec 2014 B2
8920370 Sholev et al. Dec 2014 B2
8956373 Ford et al. Feb 2015 B2
8962006 Bayon et al. Feb 2015 B2
8968762 Ladet et al. Mar 2015 B2
8979935 Lozier et al. Mar 2015 B2
9034357 Stopek May 2015 B2
9113993 Lee Aug 2015 B2
9211175 Stopek et al. Dec 2015 B2
9216075 Bailly et al. Dec 2015 B2
9346791 Liu et al. May 2016 B2
9713519 Horton et al. Jul 2017 B2
9931198 Doucet et al. Apr 2018 B2
20020087174 Capello Jul 2002 A1
20020095218 Carr et al. Jul 2002 A1
20030086975 Ringeisen May 2003 A1
20030106346 Matsumoto Jun 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040054376 Ory et al. Mar 2004 A1
20040059356 Gingras Mar 2004 A1
20040101546 Gorman et al. May 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060036266 Sulamanidze et al. Feb 2006 A1
20060116696 Odermatt et al. Jun 2006 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20060253203 Alvarado Nov 2006 A1
20060282103 Fricke et al. Dec 2006 A1
20070088391 McAlexander et al. Apr 2007 A1
20070129736 Solecki Jun 2007 A1
20070198040 Buevich et al. Aug 2007 A1
20070299538 Roeber Dec 2007 A1
20080091276 Deusch et al. Apr 2008 A1
20080109017 Herweck et al. May 2008 A1
20080113001 Herweck et al. May 2008 A1
20080172071 Barker Jul 2008 A1
20080255593 St-Germain Oct 2008 A1
20090035341 Wagener et al. Feb 2009 A1
20090036996 Roeber Feb 2009 A1
20090068250 Gravagna et al. Mar 2009 A1
20090082864 Chen et al. Mar 2009 A1
20090105526 Piroli Torelli et al. Apr 2009 A1
20090163936 Yang et al. Jun 2009 A1
20090187197 Roeber et al. Jul 2009 A1
20090192530 Adzich et al. Jul 2009 A1
20090204129 Fronio Aug 2009 A1
20090216338 Gingras et al. Aug 2009 A1
20090270999 Brown Oct 2009 A1
20090281558 Li Nov 2009 A1
20090318752 Evans et al. Dec 2009 A1
20100104608 Abuzaina et al. Apr 2010 A1
20100137679 Lashinski et al. Jun 2010 A1
20100318108 Datta et al. Dec 2010 A1
20110015760 Kullas Jan 2011 A1
20110054604 Becker Mar 2011 A1
20110144667 Horton et al. Jun 2011 A1
20110190795 Hotter et al. Aug 2011 A1
20110238094 Thomas et al. Sep 2011 A1
20110251699 Ladet Oct 2011 A1
20110257666 Ladet et al. Oct 2011 A1
20110257761 Mortarino Oct 2011 A1
20120004723 Mortarino et al. Jan 2012 A1
20120016388 Houard et al. Jan 2012 A1
20120029537 Mortarino Feb 2012 A1
20120053690 Frank Mar 2012 A1
20120065727 Reneker et al. Mar 2012 A1
20120082712 Stopek et al. Apr 2012 A1
20120116425 Intoccia et al. May 2012 A1
20120150204 Mortarino et al. Jun 2012 A1
20120165937 Montanari et al. Jun 2012 A1
20120179175 Hammell Jul 2012 A1
20120179176 Wilson et al. Jul 2012 A1
20120197415 Montanari et al. Aug 2012 A1
20120226352 Becker Sep 2012 A1
20120283826 Moses et al. Nov 2012 A1
20130178875 Horton et al. Jul 2013 A1
20130253645 Kerr et al. Sep 2013 A1
20140044861 Boey et al. Feb 2014 A1
20140100656 Namnoum et al. Apr 2014 A1
20140276993 Reilly et al. Sep 2014 A1
20140364684 Lecuivre Dec 2014 A1
Foreign Referenced Citations (142)
Number Date Country
1317836 May 1993 CA
201879864 Jun 2011 CN
19544162 Apr 1997 DE
19718903 Dec 1997 DE
19751733 Dec 1998 DE
19832634 Jan 2000 DE
10019604 Oct 2001 DE
10120942 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0263360 Apr 1988 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0531742 Mar 1993 EP
0544485 Jun 1993 EP
0552576 Jul 1993 EP
0611561 Aug 1994 EP
0614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0664132 Jul 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0800791 Oct 1997 EP
0827724 Mar 1998 EP
0836838 Apr 1998 EP
0847727 Jun 1998 EP
0876808 Nov 1998 EP
0895762 Feb 1999 EP
0898944 Mar 1999 EP
1017415 Jul 2000 EP
1036545 Sep 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1090590 Apr 2001 EP
1216717 Jun 2002 EP
1216718 Jun 2002 EP
0693523 Nov 2002 EP
1273312 Jan 2003 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1645232 Apr 2006 EP
1674048 Jun 2006 EP
1691606 Aug 2006 EP
1782848 May 2007 EP
2229918 Sep 2010 EP
3000432 Mar 2016 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2 308 349 Nov 1976 FR
2453231 Oct 1980 FR
2612392 Sep 1988 FR
2682284 Apr 1993 FR
2715309 Jul 1995 FR
2715405 Jul 1995 FR
2 724 563 Mar 1996 FR
2730406 Aug 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2773057 Jul 1999 FR
2774277 Aug 1999 FR
2779937 Dec 1999 FR
2859624 Mar 2005 FR
2863277 Jun 2005 FR
2876020 Apr 2006 FR
2884706 Oct 2006 FR
2929834 Oct 2009 FR
2953709 Jun 2011 FR
1174814 Dec 1969 GB
2 051 153 Jan 1981 GB
2306110 Apr 1997 GB
H0332677 Feb 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
H11146888 Jun 1999 JP
2008538300 Oct 2008 JP
2011078767 Apr 2011 JP
563828 Sep 2011 NZ
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9310731 Jun 1993 WO
9311805 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
WO 9507666 Mar 1995 WO
9518638 Jul 1995 WO
9532687 Dec 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
3935632 Aug 1998 WO
3949967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9906080 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
2001081667 Nov 2001 WO
2002007648 Jan 2002 WO
0217853 Mar 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004096098 Nov 2004 WO
2004103212 Dec 2004 WO
200511280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005048708 Jun 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023414 Mar 2006 WO
2007004214 Jan 2007 WO
2007048099 Apr 2007 WO
2008066883 Jun 2008 WO
2009031035 Mar 2009 WO
2009039373 Mar 2009 WO
2009071998 Jun 2009 WO
2010043978 Apr 2010 WO
2011007062 Jan 2011 WO
2011026987 Mar 2011 WO
2011038740 Apr 2011 WO
2014041577 Mar 2014 WO
Non-Patent Literature Citations (31)
Entry
European Search Report for EP17305489.1 dated Oct. 25, 2017 (3 pages).
European Search Report for EP 15305634.6 dated Nov. 2, 2015 (3 pages).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). cited byapplicant.
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, 7 pp. 189-201, 52(2),published online Nov. 2009.
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004,pp. 211-220,18(2).
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3).
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Blondin, C. et al. “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25.
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany.
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506.
Related Publications (1)
Number Date Country
20180318057 A1 Nov 2018 US